It has been proposed that the impairment of retinal circulation contributes to the pathogenesis of retinal diseases, such as diabetic retinopathy [1] [2] [3] and glaucoma. 4, 5) Therefore, agents that improve the retinal circulation would become therapeutic candidates for preventing or delaying the progression of these diseases. To develop novel therapeutics and strategies for improving the retinal circulation, we need a better understanding in the regulatory mechanisms of retinal hemodynamics.
The vascular endothelium contributes to regulation of retinal blood flow via the actions of several vasodilators, including nitric oxide (NO), prostanoids (e.g., prostaglandin I 2 ), and an endothelium-derived hyperpolarizing factor (EDHF). [6] [7] [8] [9] The large conductance, Ca 2ϩ -activated K ϩ (BK Ca ) channel is a common downstream effector of NO and prostaglandin I 2 in vasodilatory mechanisms in many blood vessels. [10] [11] [12] The BK Ca channel may also contribute to the EDHF-mediated relaxation in some blood vessels. [13] [14] [15] However, the role of BK Ca channels in regulation of the retinal circulation remains unclear. The purpose of the present study, therefore, was to examine effects of two BK Ca channel openers, BMS-191011 16, 17) and NS 1619, 18) on the rat retinal arterioles in vivo.
MATERIALS AND METHODS

Animals
Male Wistar rats (8 to 10-week-old) were maintained in a room with constant temperature (22Ϯ2°C), constant humidity (55Ϯ5%) and 12-h light/dark cycle, and allowed free access to regular rat chow and tap water. All experiments were performed in accordance with the Guidelines for Animal Experiments in Kitasato University adopted by the Committee on the Care and Use of Laboratory Animals of Kitasato University and tenets of the Association for Research in Vision and Ophthalmology statement for the Use of Animals in Ophthalmic and Vision Research.
Experimental Procedures The rats were anesthetized with pentobarbital sodium (50 mg/kg, intraperitoneally (i.p.)). After disappearance of the corneal reflex, each animal was placed on a heating pad. A tracheotomy was performed for artificial ventilation. Catheters were inserted into the femoral and jugular veins for administration of drugs. The left femoral artery was cannulated for measurement of arterial pressure, which was recorded on a thermal pen recorder (WT-645G, Nihon Kohden, Tokyo) via a pressure transducer (DX-360, Nihon Kohden) and a preamplifier (AP-610G, Nihon Kohden). Heart rate was measured with a cardiotachometer (AT-601G, Nihon Kohden) triggered by the blood pressure pulse. Mean arterial pressure and heart rate were digitized at 1 Hz (15BXW-H4; Dacs Giken, Okayama) and stored on the hard disk of a personal computer. To minimize influence of nerve activity and capture fundus images at the same angle throughout the experiment by preventing movement of the eye, rats were treated with tetrodotoxin (50 mg/kg, intravenously (i.v.)) under artificial ventilation with room air (the stroke volume, 10 ml/kg; the frequency, 80 strokes/min) using a rodent respirator (SN-480-7, Sinano, Tokyo). 19, 20) Blood pressure and heart rate were decreased by treatment with tetrodotoxin; therefore, a mixture solution of adrenaline and noradrenaline (9 : 1) continuously injected into the jugular vein at a constant rate by means of a syringe pump (Model 1140-001, Harvard Apparatus, South Natick, MA, U.S.A.) to maintain adequate systemic circulation.
Iberiotoxin (20 pmol) or the vehicle (saline) in a total volume of 10 ml was injected into the vitreous cavity of the left eye before surgical procedures and tetrodotoxin treatment described above. After the intravitreal injection, BMS-191011 (10-100 mg/kg/min) or NS 1619 (0.1-1.0 mg/kg/min) was injected into the femoral vein by means of a syringe pump (Model 1140-001, Harvard Apparatus). Intravitreal injection was performed under a microscope using a 32-gauge needle connected to a microsyringe and the needle was inserted approximately 1 mm behind the corneal limbus. Assuming a vitreous volume of 56 ml for rats, 21 ) the estimated vitreal con- , Senju Pharmaceutical, Osaka) was dropped onto the cornea to prevent drying of the eye. The optic disc was centered and focused in the field of view. Sodium fluorescein (10% solution, 0.8 ml/kg) and brilliant blue 6B (5% solution, 0.8 ml/kg) were injected into the right femoral vein to enhance contrast of blood vessel. Fundus images were captured with a digital camera (Finepix S3 pro; Fuji Photo Film, Tokyo) that was equipped with the bore scope-type objective lens for small animals (Model 01; Scalar, Tokyo) and stored on the hard disk of a laboratory computer system (Power Macintosh G3-300DT, Apple Japan, Tokyo). The region (120ϫ240 mm) including a retinal arteriole in the fundus image (2820ϫ4230 mm) was selected. The diameter of blood vessel in the same region was measured throughout the experiment as described previously. Data Analyses The diameter of the retinal arteriole, mean arterial pressure, and heart rate were expressed as percentages of the baseline values just before the infusion of BMS-191011 or NS 1619. The significance of the difference between mean values was evaluated by unpaired t-test. When comparing the responses between groups, two-way analysis of variance (ANOVA) was used. A p value of less than 0.05 was considered to represent a statistically significant difference. All values are presented as meanϮS.E.M.
RESULTS
Baseline values of the retinal arteriolar diameter, mean arterial pressure and heart rate were 41.2Ϯ1.0 mm, 113Ϯ2 mmHg and 473Ϯ9 beats/min, respectively (nϭ10). These values were not significantly different from those of rats injected intravitreally with iberiotoxin (retinal arteriolar diameter, 41.0Ϯ1.6 mm; mean arterial pressure, 110Ϯ1 mmHg; heart rate, 474Ϯ6 beats/min, nϭ10).
BMS-191011 (10-100 mg/kg/min, i.v.) increased the diameter of retinal arterioles (Fig. 1A) , whereas it had no significant effect on mean arterial pressure and heart rate (Figs. 1B, C). Intravitreal injection of iberiotoxin (20 pmol/eye) significantly attenuated the vasodilator responses to BMS-191011 of retinal arterioles (Fig. 1A) .
NS 1619 (0.1-1.0 mg/kg/min, i.v.) also increased the diameter of retinal arterioles without altering mean arterial pressure and heart rate ( Fig. 2) . However, iberiotoxin (20 pmol/eye) had no significant effect on NS 1619-indcued responses (Fig. 2) .
DISCUSSION
The BK Ca channel has been reported to act as a common downstream effector for several endogenous vasodilators, including NO and prostaglandin I 2 .
10-12,23) Nevertheless, there is little information on action of BK Ca channel openers in vivo, due to the limited availability of selective BK Ca channel openers. In this study, we assessed the effects of BMS-191011, which is a newly developed BK Ca channel opener 16, 17) and the prototype BK Ca channel opener NS 1619 18) on the rat retinal circulation. We found that both BMS-191011 and NS 1619 caused the vasodilator responses of retinal arterioles in vivo; however, the responses to BMS-191011, but not to NS 1619, were diminished by intravitreal injection of iberiotoxin. The findings suggest that activation of BK Ca channels is involved in BMS-191011-induced vasodilation of retinal arterioles. On the other hand, NS 1619 has the ability to activate BK Ca channels but it can also affect the activity of other channels, such as Ca 2ϩ channels and ATP-sensitive K ϩ channels at the same concentration range.
18) Thus, it is possible that NS 1619 dilates rat retinal arterioles through mechanism(s) other than activation of BK Ca channels.
In the present study, the BK Ca channel openers were administered intravenously because we sought to compare the significance of the BK Ca channel in regulation of retinal circulation with that of systemic circulation. The results indicate that the doses of BMS-191011 used in this study caused a significant vasodilation of retinal arterioles without decreasing systemic blood pressure. In preliminary studies, we found that the higher doses (20 mg/kg, i.v.) of this compound dramatically decreased blood pressure. At present, it is unclear whether the observed depressor responses are mediated through activation of BK Ca channels. However, our findings may suggest that the role of BK Ca channels in retinal arterioles is more important than that in peripheral resistance vessels.
Unoprostone, one of anti-glaucoma agents, has the ability to reduce intraocular pressure by stimulating receptors for prostaglandin F 2a . In addition to the lowering effect on intraocular pressure, the drug has been reported to have neuroprotective effects via an activation of iberiotoxin-sensitive BK Ca channels. 24) Therefore, selective BK Ca channel openers may behave as a vasodilator and neuroprotectant in the retina. Because endothelium-derived NO and prostaglandin I 2 act as endogenous activators of BK Ca channels, 12) NO donors and prostaglandin I 2 might also become candidates for improving the retinal circulation; however, their effects on blood pressure must be taken into consideration. On the other hand, BMS-191011 could dilate retinal arterioles at doses much lower than those needed to decrease systemic blood pressure. The vasodilator effects of BMS-191011 on retinal arterioles are, at least in part, mediated through activation of iberiotoxin-sensitive BK Ca channels. Thus, selective BK Ca channel openers would be considered as a candidate for therapeutic drugs to treat diseases associated with disorders of retinal circulation without severe cardiovascular sideeffects.
